156 related articles for article (PubMed ID: 2833398)
1. The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16-213, doxorubicin and vincristine (VPAV) for small cell lung cancer.
Cantwell BM; Bozzino JM; Corris P; Harris AL
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):123-9. PubMed ID: 2833398
[TBL] [Abstract][Full Text] [Related]
2. Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).
Ettinger DS; Finkelstein DM; Ritch PS; Lincoln ST; Blum RH;
Lung Cancer; 2002 Sep; 37(3):311-8. PubMed ID: 12234701
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
[TBL] [Abstract][Full Text] [Related]
4. Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: a phase II study of the EORTC Lung Cancer Cooperative Group.
Postmus PE; Smit EF; Kirkpatrick A; Splinter TA
Eur J Cancer; 1993; 29A(2):204-7. PubMed ID: 8380697
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
Evans WK; Stewart D; Logan D; Maroun J; Goss G; Shepherd FA; Latreille J; Warner E; Dahrouge S
Semin Oncol; 1992 Dec; 19(6 Suppl 12):51-6. PubMed ID: 1336622
[TBL] [Abstract][Full Text] [Related]
6. Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience.
Postmus PE; Smit EF; Berendsen HH; Haaxma-Reiche H
Semin Oncol; 1992 Feb; 19(1 Suppl 2):17-23. PubMed ID: 1329219
[TBL] [Abstract][Full Text] [Related]
7. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
Thomas CR; Giroux DJ; Stelzer KJ; Craig JB; Laufman LR; Taylor SA; Goodwin JW; Crowley JJ; Livingston RB
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1039-47. PubMed ID: 9539558
[TBL] [Abstract][Full Text] [Related]
8. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
[TBL] [Abstract][Full Text] [Related]
9. Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosis.
Kamthan AG; Lind MJ; Thatcher N; Steward WP; Bronchud MH; Ranson MR; Stout R
Eur J Cancer; 1990; 26(6):691-4. PubMed ID: 2168191
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.
Loehrer PJ; Ansari R; Gonin R; Monaco F; Fisher W; Sandler A; Einhorn LH
J Clin Oncol; 1995 Oct; 13(10):2594-9. PubMed ID: 7595712
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
Unsal M; Erturk D
Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
[TBL] [Abstract][Full Text] [Related]
12. Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer.
Thatcher N; Cerny T; Stout R; Anderson H; Barber PV; Wolstenholme RJ; Barnes P; Deiraniya A
Cancer; 1987 Nov; 60(10):2382-7. PubMed ID: 2822217
[TBL] [Abstract][Full Text] [Related]
13. Experience with ifosfamide and etoposide combination chemotherapy in extensive-disease small-cell lung cancer.
Wu MF; Perng RP; Chen YM; Liu JM; Yang SL; Whang-Peng J
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Aug; 60(2):67-73. PubMed ID: 9360330
[TBL] [Abstract][Full Text] [Related]
14. A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer.
Anderson H; Prendiville J; Thatcher N; Radford JA; Swindell R
J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S139-40. PubMed ID: 1665490
[TBL] [Abstract][Full Text] [Related]
15. Ifosfamide, doxorubicin, vincristine, and etoposide in small cell lung cancer.
Elisson LO; Ekberg L
Semin Oncol; 1995 Feb; 22(1 Suppl 2):15-7. PubMed ID: 7846536
[TBL] [Abstract][Full Text] [Related]
16. Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus.
Thatcher N; Lind M; Stout R; Payne C; Carroll KB; Campbell C; Moussalli H
Br J Cancer; 1989 Jul; 60(1):98-101. PubMed ID: 2553090
[TBL] [Abstract][Full Text] [Related]
17. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
18. Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.
Smith IE; Perren TJ; Ashley SA; Woodiwiss J; Forgeson GV; Yarnold JR; Ford HT
J Clin Oncol; 1990 May; 8(5):899-905. PubMed ID: 2159056
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
[TBL] [Abstract][Full Text] [Related]
20. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
